DE602006006463D1 - Indanderivate als antagonisten des mch-rezeptors - Google Patents
Indanderivate als antagonisten des mch-rezeptorsInfo
- Publication number
- DE602006006463D1 DE602006006463D1 DE602006006463T DE602006006463T DE602006006463D1 DE 602006006463 D1 DE602006006463 D1 DE 602006006463D1 DE 602006006463 T DE602006006463 T DE 602006006463T DE 602006006463 T DE602006006463 T DE 602006006463T DE 602006006463 D1 DE602006006463 D1 DE 602006006463D1
- Authority
- DE
- Germany
- Prior art keywords
- indanderivates
- antagonists
- mch receptor
- mch
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72261005P | 2005-09-30 | 2005-09-30 | |
| PCT/EP2006/066540 WO2007039462A2 (en) | 2005-09-30 | 2006-09-20 | Indane derivatives as mch receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006006463D1 true DE602006006463D1 (de) | 2009-06-04 |
Family
ID=37813513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006006463T Active DE602006006463D1 (de) | 2005-09-30 | 2006-09-20 | Indanderivate als antagonisten des mch-rezeptors |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7803816B2 (de) |
| EP (1) | EP1934199B1 (de) |
| JP (1) | JP4870163B2 (de) |
| KR (1) | KR101020333B1 (de) |
| CN (1) | CN101273026A (de) |
| AR (1) | AR056204A1 (de) |
| AT (1) | ATE429428T1 (de) |
| AU (1) | AU2006298852A1 (de) |
| BR (1) | BRPI0616646A2 (de) |
| CA (1) | CA2623722A1 (de) |
| DE (1) | DE602006006463D1 (de) |
| ES (1) | ES2322965T3 (de) |
| IL (1) | IL190152A (de) |
| TW (1) | TW200800943A (de) |
| WO (1) | WO2007039462A2 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2009001043A (es) | 2006-08-08 | 2009-02-06 | Sanofi Aventis | Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para preparalas, medicamentos que comprenden estos compuestos y su uso. |
| US7652053B2 (en) * | 2006-11-30 | 2010-01-26 | Hoffmann-La Roche Inc. | Diaminocycloalkane MCH receptor antagonists |
| US20110212053A1 (en) * | 2008-06-19 | 2011-09-01 | Dapeng Qian | Phosphatidylinositol 3 kinase inhibitors |
| AR072707A1 (es) | 2008-07-09 | 2010-09-15 | Sanofi Aventis | Compuestos heterociclicos, procesos para su preparacion, medicamentos que comprenden estos compuestos y el uso de los mismos |
| JP2010090110A (ja) * | 2008-09-12 | 2010-04-22 | Sumitomo Chemical Co Ltd | Ｎ−置換−トランス−４−アジドピペリジン−３−オールの製造方法 |
| JP2010209058A (ja) | 2008-09-29 | 2010-09-24 | Sumitomo Chemical Co Ltd | １−置換−トランス−４−（置換アミノ）ピペリジン−３−オールの製造方法 |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| UY32442A (es) | 2009-02-13 | 2010-09-30 | Sanofi Aventis | Nuevos indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento |
| ES2443016T3 (es) | 2009-08-26 | 2014-02-17 | Sanofi | Nuevos hidratos cristalinos de fluoroglicósidos heteroaromáticos, productos farmacéuticos que comprenden estos compuestos, y su empleo |
| US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683705B1 (de) | 2011-03-08 | 2015-04-22 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2683700B1 (de) | 2011-03-08 | 2015-02-18 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120055A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US10059653B2 (en) * | 2015-01-20 | 2018-08-28 | Olon S.P.A. | Process for the preparation of indanamine derivatives and new synthesis intermediates |
| KR101719321B1 (ko) * | 2016-03-31 | 2017-03-23 | 충남대학교산학협력단 | 3-(4-클로로페닐)벤조[4, 5]이미다조[2, 1-b]싸이아졸-6-카복실산을 포함하는 항비만 또는 항우울증 치료용 조성물 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4366532B2 (ja) * | 1997-05-30 | 2009-11-18 | 萬有製薬株式会社 | ２−オキソイミダゾール誘導体 |
| US6340681B1 (en) * | 1999-07-16 | 2002-01-22 | Pfizer Inc | 2-benzimidazolylamine compounds as ORL-1-receptor agonists |
| AU7315700A (en) | 1999-09-20 | 2001-04-24 | Takeda Chemical Industries Ltd. | Melanin concentrating hormone antagonist |
| KR20040011447A (ko) | 2000-12-22 | 2004-02-05 | 쉐링 코포레이션 | 피페리딘 ｍｃｈ 길항제 및 비만 치료에 있어서의 이의 용도 |
| MXPA03009600A (es) * | 2001-04-18 | 2004-04-02 | Euro Celtique Sa | Analogos de nociceptina. |
| JP2004529161A (ja) | 2001-05-04 | 2004-09-24 | トゥラリック インコーポレイテッド | 縮合複素環式化合物 |
| US7084156B2 (en) | 2001-11-27 | 2006-08-01 | Merck & Co., Inc. | 2-Aminoquinoline compounds |
| DE60319813T2 (de) * | 2002-04-18 | 2009-04-23 | Schering Corporation | 1-(4-piperidinyl)benzimidazole als histamin h3 antagonisten |
| WO2003105850A1 (en) | 2002-06-18 | 2003-12-24 | Abbott Laboratories | 2-aminoquinolines as melanin concentrating hormone receptor antagonists |
| DE10306250A1 (de) | 2003-02-14 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| EP1618112A1 (de) | 2003-04-11 | 2006-01-25 | SmithKline Beecham Corporation | Heterocyclische mchr1-antagonisten |
| US20050256161A1 (en) | 2003-08-13 | 2005-11-17 | Tempest Paul A | Melanin concentrating hormone receptor antagonists |
| EP1653960A4 (de) | 2003-08-13 | 2008-11-26 | Amgen Inc | Melanin-konzentrierender hormonrezeptor-antagonist |
| US20050040257A1 (en) | 2003-08-19 | 2005-02-24 | Seitz David M. | Atomizer with dedicated cleaning fluid system |
| TWI290140B (en) * | 2003-08-25 | 2007-11-21 | Schering Corp | 2-Substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for thr treatment of obesity and related disorders |
| WO2005034947A1 (en) | 2003-10-02 | 2005-04-21 | Schering Corporation | Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| AR045843A1 (es) * | 2003-10-03 | 2005-11-16 | Solvay Pharm Bv | Derivados de bencimidazolonas y quinazolinonas sustituidas con hidronopol como agonistas en receptores orl 1 humanos |
| JP2007509158A (ja) | 2003-10-23 | 2007-04-12 | グラクソ グループ リミテッド | 肥満、糖尿病、うつ病及び不安を治療するためのｍｃｈｒ１アンタゴニストとしての３−（４−アミノフェニル）チエノピリミド−４−オン誘導体 |
| US20050137243A1 (en) | 2003-12-23 | 2005-06-23 | Souers Andrew J. | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
-
2006
- 2006-09-20 AU AU2006298852A patent/AU2006298852A1/en not_active Abandoned
- 2006-09-20 KR KR1020087010206A patent/KR101020333B1/ko not_active IP Right Cessation
- 2006-09-20 EP EP06793670A patent/EP1934199B1/de not_active Not-in-force
- 2006-09-20 ES ES06793670T patent/ES2322965T3/es active Active
- 2006-09-20 AT AT06793670T patent/ATE429428T1/de active
- 2006-09-20 WO PCT/EP2006/066540 patent/WO2007039462A2/en active Application Filing
- 2006-09-20 JP JP2008532728A patent/JP4870163B2/ja not_active Expired - Fee Related
- 2006-09-20 CN CNA2006800354917A patent/CN101273026A/zh active Pending
- 2006-09-20 BR BRPI0616646-6A patent/BRPI0616646A2/pt not_active IP Right Cessation
- 2006-09-20 CA CA002623722A patent/CA2623722A1/en not_active Abandoned
- 2006-09-20 DE DE602006006463T patent/DE602006006463D1/de active Active
- 2006-09-25 US US11/526,523 patent/US7803816B2/en not_active Expired - Fee Related
- 2006-09-27 TW TW095135862A patent/TW200800943A/zh unknown
- 2006-09-28 AR ARP060104275A patent/AR056204A1/es not_active Application Discontinuation
-
2008
- 2008-03-13 IL IL190152A patent/IL190152A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2623722A1 (en) | 2007-04-12 |
| EP1934199A2 (de) | 2008-06-25 |
| US20070078165A1 (en) | 2007-04-05 |
| IL190152A0 (en) | 2008-08-07 |
| TW200800943A (en) | 2008-01-01 |
| JP2009510012A (ja) | 2009-03-12 |
| AU2006298852A1 (en) | 2007-04-12 |
| ATE429428T1 (de) | 2009-05-15 |
| US7803816B2 (en) | 2010-09-28 |
| BRPI0616646A2 (pt) | 2011-06-28 |
| ES2322965T3 (es) | 2009-07-02 |
| EP1934199B1 (de) | 2009-04-22 |
| CN101273026A (zh) | 2008-09-24 |
| JP4870163B2 (ja) | 2012-02-08 |
| KR101020333B1 (ko) | 2011-03-09 |
| IL190152A (en) | 2012-09-24 |
| KR20080059264A (ko) | 2008-06-26 |
| AR056204A1 (es) | 2007-09-26 |
| WO2007039462A2 (en) | 2007-04-12 |
| WO2007039462A3 (en) | 2007-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE429428T1 (de) | Indanderivate als antagonisten des mch-rezeptors | |
| ATE421511T1 (de) | Indol-3-carbonyl-spiro-piperidinderivate als antagonisten des v1a-rezeptors | |
| ATE481405T1 (de) | Thiazolpyrazolopyrimidine als antagonisten des crf1-rezeptors | |
| DK1973886T3 (da) | Prokineticin-1-receptor-antagonister | |
| DE602006015607D1 (de) | Thiazol-4-carboxamid-derivate als mglur5-antagonisten | |
| ATE505467T1 (de) | 2-aza-bicycloä3.1.0ühexanderivate als orexin- rezeptorantagonisten | |
| ATE420088T1 (de) | Chinolinoncarbonsäureamidverbindungen als 5-ht4- rezeptoragonisten | |
| DE602006019624D1 (de) | Piperidin-4-yl-pyridazin-3-yl-aminderivate als schnell dissoziierende antagonisten des dopamin-2-rezeptors | |
| ATE496051T1 (de) | Pyrazolotetrahydropyridinderivate als orexinrezeptorantagonisten | |
| DK1711465T3 (da) | Hydroisoindolin-tachykinikreceptorantagonister | |
| ATE413874T1 (de) | Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten | |
| ATE523195T1 (de) | Neue thiophen-derivate als sphingosin-1-phosphat- 1-rezeptorantagonisten | |
| ATE509928T1 (de) | 8-azabicycloä3.2.1üoktan-verbindungen als mu- opioid-rezeptorantagonisten | |
| BRPI0717937A2 (pt) | Compostos de pirazona como antagonistas do receptor mineralocorticóide | |
| ATE449091T1 (de) | Substituierte triazolderivate als oxytocinantagonisten | |
| ATE555111T1 (de) | Chinuclidinol-derivate als muscarinrezeptor- antagonisten | |
| NL2000241A1 (nl) | Carboxamidederivaten als muscarine-receptorantagonisten. | |
| DE602005009355D1 (de) | Gehinderte himbacinanaloga als thrombinrezeptorantagonisten | |
| ATE538123T1 (de) | 2-heteroarylpyrazoloä4,3-eü-1, 2, 4-triazolo-ä1,5-cü-pyrimidine als antagonisten des adenosin-a2a- rezeptors | |
| ATE533744T1 (de) | N-benzoypyrrolidin-3-ylamine als histamin-3 antagonisten | |
| ATE535523T1 (de) | Benzimidazolcarbonsäureamid-verbindungen als 5- ht4 rezeptor-agonisten | |
| ATE547407T1 (de) | Alkylthiopyrimidine als crth2-antagonisten | |
| ATE477243T1 (de) | 2-aminochinoline als 5-ht(5a)- rezeptorantagonisten | |
| DE602006003666D1 (de) | Indol-3-ylcarbonylpiperidinbenzimidazolderivate als v1a-rezeptorantagonisten | |
| ATE534628T1 (de) | Urotensin ii-rezeptorantagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |